Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week

[VUBot]

Crispr stock is down for the fifth straight week as the top Cathie Wood's holding struggles amid dim expectations for its gene-editing drug. The post Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's Why appeared first on Investor's Business Daily.

#cathiewood

Continue reading...